{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:07:07Z","timestamp":1791310027129,"version":"4.3.1"},"update-to":[{"DOI":"10.1002\/14651858.cd007803","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2015,5,10]],"date-time":"2015-05-10T00:00:00Z","timestamp":1431216000000}}],"reference-count":165,"publisher":"Wiley","issue":"5","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd007803.pub2","type":"journal-article","created":{"date-parts":[[2015,5,10]],"date-time":"2015-05-10T10:20:18Z","timestamp":1431253218000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Augmentation of cognitive and behavioural therapies (CBT) with d-cycloserine for anxiety and related disorders"],"prefix":"10.1002","volume":"2015","author":[{"given":"Rasmita","family":"Ori","sequence":"first","affiliation":[{"name":"University of Cape Town; Department of Psychiatry and Mental Health; Cape Town South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taryn","family":"Amos","sequence":"additional","affiliation":[{"name":"University of Cape Town; Department of Psychiatry and Mental Health; Cape Town South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Bergman","sequence":"additional","affiliation":[{"name":"Enhance Reviews Ltd; Central Office, Cobweb buildings The Lane, Lyford Wantage UK OX12 0EE"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karla","family":"Soares-Weiser","sequence":"additional","affiliation":[{"name":"Enhance Reviews Ltd; Central Office, Cobweb buildings The Lane, Lyford Wantage UK OX12 0EE"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan C","family":"Ipser","sequence":"additional","affiliation":[{"name":"University of Cape Town; Department of Psychiatry and Mental Health; Cape Town South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan J","family":"Stein","sequence":"additional","affiliation":[{"name":"University of Cape Town; Department of Psychiatry and Mental Health; Cape Town South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,5,10]]},"reference":[{"key":"10.1002\/14651858.CD007803.pub2-BIB0001|cit1","unstructured":"Cameron JA Use of an Antibiotic as an Enhancer for the Treatment of Social Phobia NCT00128401 ClinicalTrials.gov [www.clinicaltrials.gov]"},{"issue":"11","key":"10.1002\/14651858.CD007803.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.biopsych.2012.02.033","article-title":"A randomized placebo-controlled trial of d-cycloserine to enhance exposure therapy for posttraumatic stress disorder","volume":"71","author":"Kleine","year":"2012","journal-title":"Biological Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD007803.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jpsychires.2013.10.008","article-title":"Prescriptive variables for d-cycloserine augmentation of exposure therapy for posttraumatic stress disorder","volume":"48","author":"Kleine","year":"2014","journal-title":"Journal of Psychiatric Research"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0004|cit4","unstructured":"van Minnen A Augmentation of (imaginal) exposure therapy with D-cycloserine for patients with Posttraumatic Stress Disorder (PTSD); A Randomized Placebo controlled Study WHO International Clinical Trials Registry Platform [http:\/\/apps.who.int\/trialsearch\/Trial.aspx?TrialID=NTR1184] 2007"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0006|cit5","unstructured":"Difede J Combined Exposure Therapy and D-Cycloserine vs. Placebo for Posttraumatic Stress Disorder ClinicalTrials.gov [http:\/\/clinicaltrials.gov\/show\/NCT00632632]"},{"issue":"5","key":"10.1002\/14651858.CD007803.pub2-BIB0005|cit6","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1038\/npp.2013.317","article-title":"D-cycloserine augmentation of exposure therapy for post-traumatic stress disorder: a pilot randomized clinical trial","volume":"39","author":"Difede","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0007|cit7","unstructured":"Farrell L A randomised controlled trial to evaluate the effects of D-Cycloserine in combination with Exposure Therapy, versus pill placebo and Exposure Therapy, in the treatment of refractory pediatric Obsessive-Compulsive Disorder (OCD) to improve the severity of obsessive-compulsive (OC) symptoms WHO International Clinical Trials Registry Platform [http:\/\/apps.who.int\/trialsearch\/Trial.aspx?TrialID=ACTRN12609000370202]"},{"issue":"8","key":"10.1002\/14651858.CD007803.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/da.22132","article-title":"Difficult-to-treat pediatric obsessive-compulsive disorder: feasibility and preliminary results of a randomized pilot trial of D-cycloserine-augmented behavior therapy","volume":"30","author":"Farrell","year":"2013","journal-title":"Journal of Depression and Anxiety"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0009|cit9","unstructured":"Guastella A A randomised controlled trial to evaluate the effect of D-Cycloserine in combination with exposure therapy in the treatment of social phobia to improve the severity of social phobia symptoms WHO International Clinical Trials Registry Platform [http:\/\/apps.who.int\/trialsearch\/Trial.aspx?TrialID=ACTRN12606000352505]"},{"issue":"6","key":"10.1002\/14651858.CD007803.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.biopsych.2007.11.011","article-title":"A randomized controlled trial of D-cycloserine enhancement of exposure therapy for social anxiety disorder","volume":"63","author":"Guastella","year":"2008","journal-title":"Biological Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD007803.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1001\/archpsyc.63.3.298","article-title":"Augmentation of exposure therapy with D-cycloserine for social anxiety disorder","volume":"63","author":"Hofmann","year":"2006","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0012|cit12","unstructured":"Hofmann SG Pollack MH Smits JA D-cycloserine Enhancement of Exposure in Social Phobia ClinicalTrials.gov [http:\/\/clinicaltrials.gov\/show\/NCT00515879]"},{"issue":"7","key":"10.1002\/14651858.CD007803.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1176\/appi.ajp.2013.12070974","article-title":"D-cycloserine as an augmentation strategy with cognitive-behavioral therapy for social anxiety disorder","volume":"170","author":"Hofmann","year":"2013","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0014|cit14","unstructured":"NCT00633984 D-Cycloserine Enhancement of Exposure in Social Phobia ClinicalTrials.gov [http:\/\/clinicaltrials.gov\/show\/NCT00633984]"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0015|cit15","unstructured":"Pollack MH Smits J Simon NM Meuret A Marques L Otto MW D-Cycloserine (DCS) augmentation of CBT for social anxiety disorder: Results from an RCT abstract Biological Psychiatry. Abstracts of the 67th annual scientific convention and meeting of the Society of Biological Psychiatry May 3-5, 2012 Philadelphia, PA United States 2012 555"},{"issue":"9 Suppl 1","key":"10.1002\/14651858.CD007803.pub2-BIB0016|cit16","first-page":"30S","article-title":"Session success moderates the efficacy of cognitive enhancers for improving exposure therapy outcomes [conference abstract]","volume":"75","author":"Smits","year":"2014","journal-title":"Biological Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD007803.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1037\/a0034120","article-title":"D-cycloserine augmentation of cognitive behavioral group therapy of social anxiety disorder: prognostic and prescriptive variables","volume":"81","author":"Smits","year":"2013","journal-title":"Journal of Consulting Psychology"},{"issue":"10","key":"10.1002\/14651858.CD007803.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.jpsychires.2013.06.020","article-title":"D-cycloserine enhancement of exposure therapy for social anxiety disorder depends on the success of exposure sessions","volume":"47","author":"Smits","year":"2013","journal-title":"Journal of Psychiatric Research"},{"issue":"11","key":"10.1002\/14651858.CD007803.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1002\/da.22170","article-title":"Sleep quality predicts treatment outcome in CBT for social anxiety disorder","volume":"30","author":"Zalta","year":"2013","journal-title":"Journal of Depression and Anxiety"},{"issue":"9","key":"10.1002\/14651858.CD007803.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.biopsych.2006.12.020","article-title":"D-cycloserine augmentated exposure therapy for obsessive-compulsive disorder","volume":"62","author":"Kushner","year":"2007","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0022|cit21","unstructured":"Litz BT A Placebo-Controlled Trial of D-Cycloserine and Exposure Therapy for Combat-PTSD ClinicalTrials.gov [http:\/\/clinicaltrials.gov\/show\/NCT00371176]"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0021|cit22","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.jpsychires.2012.05.006","article-title":"A randomized placebo-controlled trial of D-cycloserine and exposure therapy for posttraumatic stress disorder","volume":"46","author":"Litz","year":"2012","journal-title":"Journal of Psychiatric Reseach"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0023|cit23","unstructured":"Euctr-006947-38-Gb A randomised double-blind placebo-controlled pilot study of D-cycloserine-augmented exposure therapy in adolescents with obsessive-compulsive disorder WHO International Clinical Trials Registry Platform [http:\/\/apps.who.int\/trialsearch\/Trial.aspx?TrialID=EUCTR2008-006947-38-GB]"},{"issue":"1","key":"10.1002\/14651858.CD007803.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1192\/bjp.bp.113.126284","article-title":"Cognitive-behavioural therapy with post-session D-cycloserine augmentation for paediatric obsessive-compulsive disorder: Pilot randomised controlled trial","volume":"204","author":"Mataix-Cols","year":"2014","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0025|cit25","unstructured":"NCT01450306 Exposure, D-cycloserine Enhancement, and fMRI in Snake Phobics ClinicalTrials.gov [http:\/\/clinicaltrials.gov\/show\/NCT01450306]"},{"issue":"9","key":"10.1002\/14651858.CD007803.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.4088\/JCP.11m07564","article-title":"Exposure therapy, D-cycloserine, and functional magnetic resonance imaging in patients with snake phobia: a randomized pilot study","volume":"73","author":"Nave","year":"2012","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0028|cit27","unstructured":"Otto MW Placebo-Controlled Evaluation of the Efficacy of D-Cycloserine for Enhancing the Effects of CBT for Panic Disorder ClinicalTrials.gov [http:\/\/clinicaltrials.gov\/show\/NCT00131339]"},{"issue":"4","key":"10.1002\/14651858.CD007803.pub2-BIB0027|cit28","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.biopsych.2009.07.036","article-title":"Efficacy of d-cycloserine for enhancing response to Cognitive-Behaviour Therapy for Panic Disorder","volume":"67","author":"Otto","year":"2010","journal-title":"Biological Psychiatry"},{"issue":"11","key":"10.1002\/14651858.CD007803.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1001\/archpsyc.61.11.1136","article-title":"Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear","volume":"61","author":"Ressler","year":"2004","journal-title":"Archives of General Psychiatry"},{"issue":"11","key":"10.1002\/14651858.CD007803.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1176\/appi.ajp.2014.14070821","article-title":"The impact of benzodiazepine management in the randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy [letter]","volume":"171","author":"Granoff","year":"2014","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0031|cit31","first-page":"S369","article-title":"Psychophysiological and cortisol reactivity predicts PTSD treatment outcome in virtual reality exposure therapy with D-cycloserine","author":"Jovanovic","year":"2014","journal-title":"Neuropsychopharmacology [abstracts of the 53rd Annual Meeting of the American College of Neuropsychopharmacology, ACNP; 2014 Dec 7-11; Phoenix, AZ United States]"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0033|cit32","unstructured":"Rothbaum BO D-cycloserine and Virtual Reality Exposure to Treat Iraq War Veterans With PTSD http:\/\/clinicaltrials.gov\/show\/NCT00356278 2006"},{"issue":"6","key":"10.1002\/14651858.CD007803.pub2-BIB0032|cit33","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1176\/appi.ajp.2014.13121625","article-title":"A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan War veterans","volume":"171","author":"Rothbaum","year":"2014","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0035|cit34","unstructured":"Scheeringa MS Effect of D-cycloserine on Treatment of PTSD in Youth ClinicalTrials.gov [http:\/\/www.clinicaltrials.gov\/ct2\/results?term=NCT01157416&Search=Search]"},{"issue":"2","key":"10.1002\/14651858.CD007803.pub2-BIB0034|cit35","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1089\/cap.2013.0106","article-title":"Randomized placebo-controlled D-cycloserine with cognitive behavior therapy for pediatric posttraumatic stress","volume":"24","author":"Scheeringa","year":"2014","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0036|cit36","article-title":"Slope of change through D-cycloserine facilitation of exposure therapy in a social anxiety population","author":"Sheerin","year":"2014","journal-title":"Dissertation Abstracts International: Section B: the Sciences and Engineering Dissertation Abstracts International 2014 75( 6-B(E))"},{"issue":"3","key":"10.1002\/14651858.CD007803.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1055\/s-0029-1202781","article-title":"The research network PANIC-NET: improving the treatment of panic disorder - from a better understanding of fear circuit mechanisms to more effective psychological treatment and routine care","volume":"59","author":"Arolt","year":"2009","journal-title":"Psychotherapie, Psychosomatik, Medizinische Psychologie"},{"issue":"8","key":"10.1002\/14651858.CD007803.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.jpsychires.2011.01.020","article-title":"D-Cycloserine does not improve but might slightly speed up the outcome of in-vivo exposure therapy in patients with severe agoraphobia and panic disorder in a randomized double blind clinical trial","volume":"45","author":"Siegmund","year":"2011","journal-title":"Journal of Psychiatric Research"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0039|cit39","unstructured":"Strohle A D-cycloserine-supported exposure in patients with panic disorder WHO International Clinical Trials Registry Platform [http:\/\/apps.who.int\/trialsearch\/Trial.aspx?TrialID=ISRCTN44960833]"},{"issue":"4","key":"10.1002\/14651858.CD007803.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/YIC.0b013e32819f8480","article-title":"D-cycloserine does not enhance exposure-response prevention therapy in obsessive-compulsive disorder","volume":"22","author":"Storch","year":"2007","journal-title":"International Clinical Psychopharmacology"},{"issue":"5","key":"10.1002\/14651858.CD007803.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s10826-013-9742-1","article-title":"Does D-cycloserine augmentation of CBT improve therapeutic homework compliance for pediatric obsessive-compulsive disorder?","volume":"23","author":"Park","year":"2014","journal-title":"Journal of Child and Family Studies"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0042|cit42","unstructured":"Storch E D-Cycloserine Augmentation of Therapy for Pediatric Obsessive-Compulsive Disorder ClinicaTrials.gov [http:\/\/clinicaltrials.gov\/show\/NCT00864123]"},{"issue":"11","key":"10.1002\/14651858.CD007803.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.biopsych.2010.07.015","article-title":"A preliminary study of d-cycloserine augmentation of cognitive-behavioural therapy in pediatric obsessive-compulsive disorder","volume":"68","author":"Storch","year":"2010","journal-title":"Biological Psychiatry"},{"issue":"11","key":"10.1002\/14651858.CD007803.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.biopsych.2012.12.009","article-title":"D-cycloserine enhancement of fear extinction is specific to successful exposure sessions: Evidence from the treatment of height phobia","volume":"73","author":"Smits","year":"2013","journal-title":"Biological Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD007803.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jpsychires.2012.09.024","article-title":"Augmentation of exposure therapy with post-session administration of d-cycloserine","volume":"47","author":"Tart","year":"2013","journal-title":"Journal of Psychiatric Research"},{"issue":"7","key":"10.1002\/14651858.CD007803.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.brat.2010.03.007","article-title":"Need for speed: Evaluating the slopes of OCD recovery in behaviour therapy enhanced with D-cycloserine","volume":"48","author":"Chasson","year":"2010","journal-title":"Behavioural Research and Therapy"},{"issue":"3","key":"10.1002\/14651858.CD007803.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1176\/appi.ajp.2007.07050776","article-title":"Augmentation of behaviour therapy with d-cycloserine for obsessive-compulsive disorder","volume":"165","author":"Wilhelm","year":"2008","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0048|cit48","unstructured":"Wilhelm S Tolin D A Randomized, Double-blind, Placebo-controlled Medication Trial With D-Cycloserine for Individuals With Obsessive-compulsive Disorder Currently Receiving Behavior Therapy ClinicalTrials.gov [http:\/\/clinicaltrials.gov\/show\/NCT00126282]"},{"issue":"4","key":"10.1002\/14651858.CD007803.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.janxdis.2010.02.009","article-title":"D-cycloserine for the augmentation of an attentional training intervention for trait anxiety","volume":"24","author":"Behar","year":"2010","journal-title":"Journal of Anxiety Disorders"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0050|cit50","unstructured":"Evins AE Cognitive remediation with D-cycloserine added to cue exposure therapy 51st Annual Meeting of the American College of Neuropsychopharmacology, Acnp; 2012 Feb 2-6; Hollywood, FL United States 2012"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0051|cit51","unstructured":"Galovic N Rapee R The effect of D-Cycloserine on imaginal and in-vivo exposure therapy for public speaking anxiety WHO International Clinical Trials Registry Platform [http:\/\/apps.who.int\/trialsearch\/Trial.aspx?TrialID=ACTRN12610000587000] 2010"},{"issue":"6","key":"10.1002\/14651858.CD007803.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jpsychires.2006.05.006","article-title":"A randomized controlled trial of the effect of d-cycloserine on exposure therapy for spider fear","volume":"41","author":"Guastella","year":"2007","journal-title":"Journal of Psychiatric Research"},{"issue":"4","key":"10.1002\/14651858.CD007803.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.brat.2006.07.005","article-title":"A randomised control trial of the effect of D-cycloserine on extinction and fear conditioning in humans","volume":"45","author":"Guastella","year":"2007","journal-title":"Behaviour Research and Therapy"},{"issue":"4","key":"10.1002\/14651858.CD007803.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/16506073.2012.711770","article-title":"The effect of D-cycloserine on subliminal cue exposure in spider fearful individuals","volume":"41","author":"Gutner","year":"2012","journal-title":"Cognitive Behaviour Therapy"},{"issue":"4","key":"10.1002\/14651858.CD007803.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1017\/S1461145702003061","article-title":"Pilot-controlled trial of D-cycloserine for the treatment of post-traumatic stress disorder","volume":"5","author":"Heresco-Levy","year":"2002","journal-title":"International Journal of Neuropsychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD007803.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jpsychires.2012.08.027","article-title":"Sex differences in fear conditioning in posttraumatic stress disorder","volume":"47","author":"Inslicht","year":"2013","journal-title":"Journal of Psychiatric Research"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0057|cit57","unstructured":"Levinson CA A Double Blind Clinical Trial of DCS for Food Anxiety for Patients With Anorexia and Bulimia Nervosa http:\/\/clinicaltrials.gov\/show\/NCT01996644 2013"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0058|cit58","unstructured":"NCT00257361 D-Cycloserine Augmentation of Exposure and Response Prevention Treatment for Obsessive-Compulsive Disorder ClinicalTrials.gov [http:\/\/clinicaltrials.gov\/show\/NCT00257361] 2005"},{"issue":"7","key":"10.1002\/14651858.CD007803.pub2-BIB0059|cit59","first-page":"592","article-title":"D-cycloserine for treatment of numbing and avoidance in chronic post traumatic stress disorder: A randomized, double blind, clinical trial","volume":"19","author":"Attari","year":"2014","journal-title":"Journal of Research in Medical Sciences"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0060|cit60","unstructured":"Rajabi F Efficacy of D-Cycloserine for Treatment of Numbing and Avoidance in patients with Chronic PTSD - D-Cycloserine for Numbing and Avoidance in Chronic PTSD WHO International Clinical Trials Registry Platform [http:\/\/apps.who.int\/trialsearch\/] 2013"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0061|cit61","doi-asserted-by":"crossref","unstructured":"Rodebaugh TL Levinson CA Lenze EJ A high-throughput clinical assay for testing drug facilitation of exposure therapy Depression and Anxiety 2013 631 7","DOI":"10.1002\/da.22047"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0062|cit62","unstructured":"Sharp WG Use of D-cycloserine to Facilitate Extinction of Food Aversion in Pediatric Populations http:\/\/clinicaltrials.gov\/show\/NCT01923896 2013"},{"issue":"4","key":"10.1002\/14651858.CD007803.pub2-BIB0063|cit63","first-page":"238","article-title":"The application of exposure therapy and D-cycloserine to the treatment of anorexia nervosa: a preliminary trial","volume":"13","author":"Steinglass","year":"2007","journal-title":"Journal of Psychiatric Research"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0064|cit64","article-title":"D-cycloserine enhancement of exposure and response prevention therapy in OCD and panic disorder with agoraphobia: a randomised controlled trial","author":"Cath","year":"2009","journal-title":"http:\/\/www.trialregister.nl\/trialreg\/admin\/rctview.asp?TC=2050"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0065|cit65","unstructured":"Euctr-021198-35-Nl D-cycloserine (DCS) enhancement of exposure therapy in panic disorder with agoraphobia: a randomized controlled trial - D-cycloserine enhancement of exposure therapy WHO International Clinical Trials Registry Platform [http:\/\/apps.who.int\/trialsearch\/Trial.aspx?TrialID=EUCTR2010-021198-35-NL]"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0066|cit66","article-title":"D-Cycloserine enhancement in exposure therapy for patients with a panic disorder with agoraphobia; a randomised controlled trial","author":"Klein Hofmeijer","year":"2014","journal-title":"European Neuropsychopharmacology 2014 S617 [abstracts of the 27th European College of Neuropsychopharmacology, ECNP Congress; 2014 Oct 18-21; Berlin Germany]"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0067|cit67","unstructured":"Cath DC D-cycloserine enhancement of exposure and response prevention therapy in OCD and panic disorder with agoraphobia: a randomised controlled trial http:\/\/www.trialregister.nl\/trialreg\/admin\/rctview.asp?TC=2050 2009"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0068|cit68","unstructured":"Guay S RCT of CBT combined with d-cycloserine for treating PTSD or comparative study of the efficacy of a cognitive-behavioral therapy for post-traumatic stress disorder with or without d-cycloserine NCT00452231 Clinicaltrials.gov [www.clinicaltrials.gov] 2007"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0069|cit69","unstructured":"Strohle A Augmentation of Exposure Therapy With D-Cycloserine in Patients With Agoraphobia With or Without Panic Disorder http:\/\/clinicaltrials.gov\/show\/NCT01928823 2011"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0070|cit70","unstructured":"Arman S Soheilimehr A The efficacy of augment of D-cycloserine and cognitive-behavioral therapy on symptoms improvement in the adolescents with one type of anxiety disorders: A double-blind randomized controlled trial WHO International Clinical Trials Registry Platform [http:\/\/apps.who.int\/trialsearch\/Trial.aspx?TrialID=IRCT2012071610297N1] 2013"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0071|cit71","unstructured":"Bergman L The Use of D-Cycloserine to Augment Intensive Cognitive Behavioral Therapy for Pediatric Obsessive Compulsive Disorder http:\/\/clinicaltrials.gov\/show\/NCT01687140 2012"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0072|cit72","unstructured":"Meerkanten GGZ The effect of the addition of D-cycloserine to exposure sessions in the treatment of patients with obsessive-compulsive disorder. A randomized, placebo-controlled trial WHO International Clinical Trials Registry Platform [http:\/\/apps.who.int\/trialsearch\/Trial.aspx?TrialID=EUCTR2007-000367-18-NL] 2007"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0073|cit73","unstructured":"de Leeuw AS The effect of the addition of D-cycloserine to exposure sessions in the treatment of patients with obsessive-compulsive disorder. A randomized, placebo-controlled trial [Onderzoek naar het effect van de toevoeging van D-cycloserine aan exposure sessies bij de behandeling van pati\u00ebnten met een obsessieve-compulsieve stoornis] http:\/\/www.trialregister.nl\/trialreg\/admin\/rctview.asp?TC=1189 2008"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0074|cit74","unstructured":"Difede J D-cycloserine Enhanced Imaginal ExposureTherapy for Posttraumatic Stress Disorder (PTSD) http:\/\/clinicaltrials.gov\/show\/NCT00875342 2009"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0075|cit75","unstructured":"Difede J Enhancing Exposure Therapy for Post Traumatic Stress Disorder (PTSD): Virtual Reality and Imaginal Exposure With a Cognitive Enhancer http:\/\/clinicaltrials.gov\/show\/NCT01352637 2011"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0076|cit76","unstructured":"Farrell L A randomised controlled trial to evaluate the effects of D-cycloserine in combination with exposure therapy, versus pill placebo and exposure therapy, in the treatment of pediatric Specific Phobia to improve symptoms of anxiety, fear and phobic avoidance WHO International Clinical Trials Registry Platform [http:\/\/apps.who.int\/trialsearch\/Trial.aspx?TrialID=ACTRN12612000420842] 2012"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0077|cit77","unstructured":"Farrell I A randomised controlled trial to evaluate the effects of D-cycloserine in combination with intensive exposure therapy, versus pill placebo in combination with intensive exposure therapy in the treatment of pediatric Obsessive Compulsive Disorder to improve the severity of obsessive compulsive symptoms http:\/\/www.anzctr.org.au\/ACTRN12614000140651.aspx 2014"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0078|cit78","unstructured":"Geller DA 2\/2 D-Cycloserine Augmentation of CBT for Pediatric OCD http:\/\/clinicaltrials.gov\/show\/NCT01404208 2011"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0079|cit79","unstructured":"Guastella A A randomised controlled trial to evaluate the effects of D-Cycloserine in combination with Exposure Therapy in the treatment of panic disorder to improve the severity of Panic Symptoms WHO International Clinical Trials Registry Platform [http:\/\/apps.who.int\/trialsearch\/Trial.aspx?TrialID=ACTRN12606000351516] 2006"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0080|cit80","unstructured":"Otto MW Tolin DF Pollack MH Exposure, D-Cycloserine Enhancement, and Genetic Modulators in Panic Disorder http:\/\/clinicaltrials.gov\/show\/NCT00790868 2008"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0081|cit81","unstructured":"Pollack M Hofmann S Smits JA Dose Timing of D-Cycloserine to Augment CBT for Social Anxiety Disorder http:\/\/clinicaltrials.gov\/show\/NCT02066792 2014"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0082|cit82","unstructured":"Rapee R Byrne S Among Spider and Dog Phobic Children is D-Cycloserine Augmented Exposure Therapy more Effective than Exposure Therapy alone as Measured by Performance on Behavioural Approach Tests WHO International Clinical Trials Registry Platform [http:\/\/apps.who.int\/trialsearch\/Trial.aspx?TrialID=ACTRN12610000490077] 2010"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0083|cit83","unstructured":"Rapee R D-cycloserine vs placebo combined with in-vivo exposure in the reduction of specific fears among children with broad-based anxiety disorders WHO International Clinical Trials Registry Platform [http:\/\/apps.who.int\/trialsearch\/Trial.aspx?TrialID=ACTRN12611000660987] 2011"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0084|cit84","unstructured":"Reinecke A Harmer C The Effect of a Single-dose of D-cycloserine on the Basic Effects of Cognitive-behaviour Therapy for Panic Disorder - a Randomized Placebo-controlled Trial http:\/\/clinicaltrials.gov\/show\/NCT01680107 2012"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0085|cit85","unstructured":"Ruck C Internet-based Cognitive Behavior Therapy in Combination With D-Cycloserine for Obsessive Compulsive Disorder: A Double Blinded Randomized Controlled Trial http:\/\/clinicaltrials.gov\/show\/NCT01649895 2012"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0086|cit86","unstructured":"Sirbu C Kerr PL D-Cycloserine-Enhancer of One-Session Treatment for Phobia of Heights http:\/\/clinicaltrials.gov\/show\/NCT01037101 2009"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0087|cit87","unstructured":"Smits JA Enhancing Panic and Smoking Reduction Treatment With D-Cycloserine http:\/\/clinicaltrials.gov\/show\/NCT01944423 2013"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0088|cit88","unstructured":"Storch EA 1\/2 D-cycloserine Augmentation of CBT for Pediatric OCD http:\/\/clinicaltrials.gov\/show\/NCT01411774 2011"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0089|cit89","first-page":"21","article-title":"Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project","volume":"420","author":"Alonso","year":"2004","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0090|cit90","volume-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-III)","author":"American Psychiatric Association","year":"1980"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0091|cit91","volume-title":"Diagnostic and statistical manual of mental disorders (DSM-IV)","author":"American Psychiatric Association","year":"1994"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0092|cit92","volume-title":"Diagnostic and statistical manual of mental disorders (DSM-IV-TR)","author":"American Psychiatric Association","year":"2000"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0093|cit93","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and statistical manual of mental disorders (5th ed.)","author":"American Psychiatric Association","year":"2013"},{"issue":"5","key":"10.1002\/14651858.CD007803.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1017\/S1461145710001434","article-title":"Evidence-based pharmacological treatment of generalized anxiety disorder","volume":"14","author":"Baldwin","year":"2011","journal-title":"International Journal of Neuropsychopharmacology"},{"issue":"10","key":"10.1002\/14651858.CD007803.pub2-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1017\/S1092852900022379","article-title":"Treatment-resistant panic disorder","volume":"9","author":"Bandelow","year":"2004","journal-title":"CNS Spectrums"},{"issue":"4","key":"10.1002\/14651858.CD007803.pub2-BIB0096|cit96","first-page":"248","article-title":"World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders","volume":"9","author":"Bandelow","year":"2008","journal-title":"Informa Healthcare"},{"issue":"19","key":"10.1002\/14651858.CD007803.pub2-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1001\/jama.283.19.2529","article-title":"Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial","volume":"283","author":"Barlow","year":"2000","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","article-title":"An inventory for measuring depression","volume":"4","author":"Beck","year":"1961","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0099|cit99","volume-title":"Beck Anxiety Inventory","author":"Beck","year":"1993"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0100|cit100","volume-title":"Beck Youth Inventories","author":"Beck","year":"2001"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0101|cit101","article-title":"Screen for Child Anxiety Related Disorders (SCARED)\u2013Parent form and child form (8 years and older)","volume-title":"Innovations in Clinical Practice: Focuson Children & Adolescents, edited by L. VandeCreek and T.L. Jackson","author":"Birmaher","year":"2003"},{"issue":"10 Suppl 12","key":"10.1002\/14651858.CD007803.pub2-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1017\/S1092852900025827","article-title":"Efficacy of combined pharmacotherapy and psychotherapy versus monotherapy in the treatment of anxiety disorders","volume":"11","author":"Black","year":"2006","journal-title":"CNS Spectrums"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0103|cit103","first-page":"187","article-title":"A clinician rating scale for assessing current and lifetime PTSD: The CAPS-1","volume":"21","author":"Blake","year":"1990","journal-title":"Behavior Therapy"},{"issue":"2","key":"10.1002\/14651858.CD007803.pub2-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0006-8993(93)91239-O","article-title":"Desensitization of the NMDA receptor complex by glycinergic ligands in cerebellar granule cell cultures","volume":"603","author":"Boje","year":"1993","journal-title":"Brain Research"},{"issue":"4","key":"10.1002\/14651858.CD007803.pub2-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"533","DOI":"10.4088\/JCP.11r07356","article-title":"D-cycloserine augmentation of behaviour therapy for treatment of anxiety disorders: Meta-analysis","volume":"73","author":"Bontempo","year":"2012","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0106|cit106","volume-title":"Anxiety Disorders Interview Schedule for DSM-IV","author":"Brown","year":"1989"},{"issue":"8 Suppl 2","key":"10.1002\/14651858.CD007803.pub2-BIB0107|cit107","first-page":"9S","article-title":"Clinical practice guidelines. Management of anxiety disorders","volume":"51","author":"Canadian Psychiatric Association","year":"2006","journal-title":"Canadian Journal of Psychiatry"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.biopsych.2006.03.084","article-title":"Effects of d-cycloserine on extinction: translation from preclinical to clinical work","volume":"60","author":"Davis","year":"2006","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0109|cit109","article-title":"Analysing and presenting results","volume-title":"Cochrane Reviewers\u2019 Handbook 5.0.0 [updated February] Section 9;","author":"Deeks","year":"2008"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0110|cit110","article-title":"Chapter 9: Analysing data and undertaking meta-analyses","volume-title":"In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March2011]","author":"Deeks","year":"2011"},{"issue":"5","key":"10.1002\/14651858.CD007803.pub2-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1038\/npp.2013.317","article-title":"D-cycloserine augmentation of exposure therapy for post-traumatic stress disorder: a pilot randomized clinical trial","volume":"39","author":"Difede","year":"2014","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD007803.pub2-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1037\/0033-2909.99.1.20","article-title":"Emotional processing of fear: exposure to corrective information","volume":"99","author":"Foa","year":"1986","journal-title":"Psychological Bulletin"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1207\/S15374424JCCP3003_9","article-title":"The child PTSD symptom scale (CPSS): A preliminary examination of its psychometric properties","volume":"30","author":"Foa","year":"2001","journal-title":"Journal of Clinical Child Psychology"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0114|cit114","doi-asserted-by":"crossref","DOI":"10.1093\/med:psych\/9780195308501.001.0001","volume-title":"Prolonged Exposure Therapy for PTSD: Emotional Processing of Traumatic Experiences Therapist Guide","author":"Foa","year":"2007"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1192\/bjp.188.4.305","article-title":"Psychotherapy plus antidepressant for panic disorder with or without agoraphobia: systematic review","volume":"188","author":"Furukawa","year":"2006","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1001\/archpsyc.1989.01810110048007","article-title":"The Yale-Brown Obsessive Compulsive Scale, I: development, use, and reliability","volume":"46","author":"Goodman","year":"1989","journal-title":"Archives of General Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD007803.pub2-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/oxfordjournals.aje.a114593","article-title":"Interpretation and choice of effect measures in epidemiologic analyses","volume":"125","author":"Greenland","year":"1987","journal-title":"American Journal of Epidemiology"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0118|cit118","volume-title":"ECDEU assessment manual for psychopharmacology","author":"Guy","year":"1976"},{"issue":"6","key":"10.1002\/14651858.CD007803.pub2-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0120|cit120","doi-asserted-by":"crossref","DOI":"10.1002\/9780470712184.ch8","article-title":"Assessing risk of bias in included studies","volume-title":"Cochrane Reviewers\u2019 Handbook 5.0.0 [updated February] Section 8;","author":"Higgins","year":"2008"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0121|cit121","doi-asserted-by":"crossref","DOI":"10.1002\/9780470712184.ch16","article-title":"Special topics in statistics","volume-title":"Cochrane Reviewers\u2019 Handbook 5.0.0 [updated February] Section 16","author":"Higgins","year":"2008"},{"issue":"1","key":"10.1002\/14651858.CD007803.pub2-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1467-985X.2008.00552.x","article-title":"A re-evaluation of random-effects meta-analysis","volume":"172","author":"Higgins","year":"2009 Jan","journal-title":"Journal of the Royal Statistical Society: Series A (Statistics in Society)"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0123|cit123","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]","author":"Higgins","year":"2011"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1521\/ijct.2009.2.2.160","article-title":"Is it beneficial to add pharmacotherapy to cognitive-behavioral therapy when treating anxiety disorders? A meta-analytic review","volume":"2","author":"Hofmann","year":"2009","journal-title":"International Journal of Cognitive Therapy"},{"issue":"2","key":"10.1002\/14651858.CD007803.pub2-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.pbb.2010.11.020","article-title":"Cognitive Enhancers for Anxiety Disorders","volume":"99","author":"Hofmann","year":"2011","journal-title":"Pharmacology Biochemistry and Behavior"},{"issue":"3","key":"10.1002\/14651858.CD007803.pub2-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/da.22257","article-title":"d-Cycloserine for treatment of anxiety disorders - making good exposures better and bad exposures worse","volume":"31","author":"Hofmann","year":"2014 March","journal-title":"Depression and Anxiety"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1007\/s11920-014-0532-2","article-title":"d-Cycloserine Augmentation of Cognitive Behaviour Therapy for Anxiety disorders: an update","volume":"17","author":"Hofmann","year":"2015","journal-title":"Current Psychiatry Reports"},{"issue":"3","key":"10.1002\/14651858.CD007803.pub2-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1056\/NEJMcp031002","article-title":"Clinical practice. Obsessive-compulsive disorder","volume":"350","author":"Jenike","year":"2004","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD007803.pub2-BIB0129|cit129","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003153","article-title":"D-cycloserine for Alzheimer's disease","author":"Jones","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD007803.pub2-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1001\/archpsyc.1994.03950010008002","article-title":"Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey","volume":"51","author":"Kessler","year":"1994","journal-title":"Archives of General Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD007803.pub2-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1001\/archpsyc.62.6.593","article-title":"Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication","volume":"62","author":"Kessler","year":"2005","journal-title":"Archives of General Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD007803.pub2-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0005-7894(74)80008-0","article-title":"Psychometric description of some specific fear questionnaires","volume":"5","author":"Klorman","year":"1974","journal-title":"Behavior Therapy"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0133|cit133","volume-title":"Children\u2019s Depression Inventory Manual","author":"Kovacs","year":"1992"},{"issue":"2","key":"10.1002\/14651858.CD007803.pub2-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1037\/0735-7044.117.2.341","article-title":"Effects of D-cycloserine on extinction of conditioned freezing","volume":"117","author":"Ledgerwood","year":"2003","journal-title":"Behavioral Neuroscience"},{"issue":"8","key":"10.1002\/14651858.CD007803.pub2-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.biopsych.2005.01.023","article-title":"D-cycloserine facilitates extinction of learned fear: effects on reacquisition and generalized extinction","volume":"57","author":"Ledgerwood","year":"2005","journal-title":"Biological Psychiatry"},{"issue":"20","key":"10.1002\/14651858.CD007803.pub2-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"8444","DOI":"10.1523\/JNEUROSCI.18-20-08444.1998","article-title":"Amygdalar NMDA receptors are critical for new fear learning in previously fear-conditioned rats","volume":"18","author":"Lee","year":"1998","journal-title":"The Journal of Neuroscience"},{"issue":"39","key":"10.1002\/14651858.CD007803.pub2-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"10051","DOI":"10.1523\/JNEUROSCI.2466-06.2006","article-title":"Reconsolidation and extinction of conditioned fear: inhibition and potentiation","volume":"26","author":"Lee","year":"2006","journal-title":"The Journal of Neuroscience"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000414022","article-title":"Social phobia","volume":"22","author":"Liebowitz","year":"1987","journal-title":"Modern Problems in Pharmacopsychiatry"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1001\/archpsyc.49.4.290","article-title":"Phenelzinevs atenolol in social phobia: a placebo-controlled comparison","volume":"49","author":"Liebowitz","year":"1992","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/00004583-199704000-00019","article-title":"The Multidimensional Anxiety Scale for Children: Factor structure, reliability, and validity","volume":"36","author":"March","year":"1997","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0141|cit141","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1192\/bjp.162.6.776","article-title":"Alprazolam and exposure alone and combined in panic disorder with agoraphobia. A controlled study in London and Toronto","volume":"162","author":"Marks","year":"1993","journal-title":"British Journal of Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD007803.pub2-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1176\/appi.ajp.157.5.669","article-title":"Quality of life in individuals with anxiety disorders","volume":"157","author":"Mendlowicz","year":"2000","journal-title":"American Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD007803.pub2-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jad.2005.05.003","article-title":"A meta-analysis of the efficacy of psycho- and pharmacotherapy in panic disorder with and without agoraphobia","volume":"88","author":"Mitte","year":"2005 Sept","journal-title":"Journal of Affective Disorders"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0144|cit144","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1056\/NEJMra1201534","article-title":"Measuring the Global burden of disease","volume":"369","author":"Murray","year":"2013","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0145|cit145","article-title":"Generalised Anxiety Disorder and Panic Disorder (With Or Without Agoraphobia) in Adults: Management in Primary, Secondary and Community Care","volume":"113","author":"NICE","year":"2011","journal-title":"NICE clinical guideline 113. Available at www.nice.org.uk\/CG113[NICE guideline]"},{"issue":"12","key":"10.1002\/14651858.CD007803.pub2-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.biopsych.2008.01.012","article-title":"A meta-analysis of D-cycloserine and the facilitation of fear extinction and exposure therapy","volume":"63","author":"Norberg","year":"2008","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1017\/S1461145702002900","article-title":"Treatment non-response in OCD: methodological and operational definitions","volume":"5","author":"Pallanti","year":"2002","journal-title":"International Journal of Neuropsychopharmacology"},{"issue":"16","key":"10.1002\/14651858.CD007803.pub2-BIB0148|cit148","doi-asserted-by":"crossref","first-page":"6225","DOI":"10.1523\/JNEUROSCI.20-16-06225.2000","article-title":"The role of ventromedial prefrontal cortex in the recovery of extinguished fear","volume":"20","author":"Quirk","journal-title":"The Journal of Neuroscience"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0149|cit149","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1192\/bjp.bp.106.028167","article-title":"Treatment of social phobia through pure self help and therapist-augmented self help","volume":"191","author":"Rapee","year":"2007","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0150|cit150","first-page":"2","article-title":"Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders","volume":"12 Suppl 1","author":"Ressler","year":"November 2000","journal-title":"Depression and anxiety"},{"issue":"5","key":"10.1002\/14651858.CD007803.pub2-BIB0151|cit151","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1101\/lm.78204","article-title":"Facilitation of fear extinction by D-cycloserine: theoretical and clinical implications","volume":"11","author":"Richardson","year":"2004","journal-title":"Learning and Memory"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0152|cit152","doi-asserted-by":"crossref","unstructured":"Rodrigues H Figueira I Lopes A Gon\u00e7alves R Mendlowicz MV Coutinho ESF Ventura P Does D-cycloserine enhance exposure therapy for anxiety disorders in humans? A meta-analysis PLOS ONE July 2014","DOI":"10.1371\/journal.pone.0093519"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0153|cit153","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1196\/annals.1301.012","article-title":"Applying learning principles to the treatment of post-trauma reactions","volume":"1008","author":"Rothbaum","year":"Dec 2003","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0154|cit154","first-page":"844","article-title":"The Children\u2019s Yale-Brown Obsessive-Compulsive Scale: preliminary report of reliability and validity","volume":"36","author":"Scahill","year":"1997","journal-title":"JAACAP"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0155|cit155","unstructured":"Sch\u00fcnemann HJ Oxman AD Vist GE Higgins JPT Deeks JJ Glasziou P Interpreting results and drawing conclusions Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions The Cochrane Collaboration"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0156|cit156","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1056\/NEJM199305133281907","article-title":"Use of benzodiazepines in anxiety disorders","volume":"328","author":"Shader","year":"1993","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0157|cit157","volume-title":"Manual for the State-Trait Anxiety Inventory","author":"Spielberger","year":"1970"},{"issue":"4","key":"10.1002\/14651858.CD007803.pub2-BIB0158|cit158","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2174\/1573400510666140619224942","article-title":"The future of D-cycloserine and other cognitive modifiers in obsessive - compulsive and related disorders","volume":"10","author":"Sulkowski","year":"2014","journal-title":"Current Psychiatry Reviews"},{"issue":"1","key":"10.1002\/14651858.CD007803.pub2-BIB0159|cit159","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/hipo.10043","article-title":"The role of NMDA glutamate receptors, PKA, MAPK, and CAMKII in the hippocampus in extinction of conditioned fear","volume":"13","author":"Szapiro","year":"2003","journal-title":"Hippocampus"},{"issue":"6965","key":"10.1002\/14651858.CD007803.pub2-BIB0160|cit160","doi-asserted-by":"crossref","first-page":"1351\u20135","DOI":"10.1136\/bmj.309.6965.1351","article-title":"Why sources of heterogeneity in meta analysis should be investigated","volume":"309","author":"Thompson","year":"1994","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD007803.pub2-BIB0161|cit161","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003730.pub2","article-title":"Glutamatergic drugs for schizophrenia","author":"Tiihonen","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0162|cit162","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1523\/JNEUROSCI.22-06-02343.2002","article-title":"Facilitation of conditioned fear extinction by systemic administration or intra-amygdala infusions of D-cycloserine as assessed with fear-potentiated startle","volume":"22","author":"Walker","year":"2002","journal-title":"Journal of Neuroscience"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0163|cit163","unstructured":"World Health Organization The ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research World Health Organization 1993"},{"issue":"1","key":"10.1002\/14651858.CD007803.pub2-BIB0164|cit164","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.neuroscience.2005.04.003","article-title":"Facilitation of conditioned fear extinction by d-cycloserine is mediated by mitogen-activated protein kinase and phosphatidylinositol 3-kinase cascades and requires de novo protein synthesis in basolateral nucleus of amygdala","volume":"134","author":"Yang","year":"2005","journal-title":"Neuroscience"},{"key":"10.1002\/14651858.CD007803.pub2-BIB0165|cit165","unstructured":"Yates RW David Bienenfeld D Bessman E Brenner B Daniels C Erickson M Friedman S Anxiety Disorders Medscape Emedicine January 2012"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD007803.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T16:37:08Z","timestamp":1725467828000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD007803.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Common Mental Disorders Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,5,10]]},"references-count":165,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2015,5]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd007803.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,10]]}}}